nodes	percent_of_prediction	percent_of_DWPC	metapath
Desoximetasone—Dermatitis perioral—Tretinoin—peripheral nervous system neoplasm	0.0304	0.0306	CcSEcCtD
Desoximetasone—Dermatitis perioral—Isotretinoin—peripheral nervous system neoplasm	0.0304	0.0306	CcSEcCtD
Desoximetasone—Telangiectasia—Isotretinoin—peripheral nervous system neoplasm	0.0293	0.0295	CcSEcCtD
Desoximetasone—Telangiectasia—Tretinoin—peripheral nervous system neoplasm	0.0293	0.0295	CcSEcCtD
Desoximetasone—Application site pruritus—Tretinoin—peripheral nervous system neoplasm	0.0283	0.0285	CcSEcCtD
Desoximetasone—Application site pruritus—Isotretinoin—peripheral nervous system neoplasm	0.0283	0.0285	CcSEcCtD
Desoximetasone—Acneiform eruption—Tretinoin—peripheral nervous system neoplasm	0.0273	0.0275	CcSEcCtD
Desoximetasone—Acneiform eruption—Isotretinoin—peripheral nervous system neoplasm	0.0273	0.0275	CcSEcCtD
Desoximetasone—Miliaria—Tretinoin—peripheral nervous system neoplasm	0.0235	0.0237	CcSEcCtD
Desoximetasone—Miliaria—Isotretinoin—peripheral nervous system neoplasm	0.0235	0.0237	CcSEcCtD
Desoximetasone—Secondary infection—Tretinoin—peripheral nervous system neoplasm	0.0235	0.0237	CcSEcCtD
Desoximetasone—Secondary infection—Isotretinoin—peripheral nervous system neoplasm	0.0235	0.0237	CcSEcCtD
Desoximetasone—Dermatitis perioral—Alitretinoin—peripheral nervous system neoplasm	0.023	0.0232	CcSEcCtD
Desoximetasone—Skin atrophy—Isotretinoin—peripheral nervous system neoplasm	0.0228	0.023	CcSEcCtD
Desoximetasone—Skin atrophy—Tretinoin—peripheral nervous system neoplasm	0.0228	0.023	CcSEcCtD
Desoximetasone—Telangiectasia—Alitretinoin—peripheral nervous system neoplasm	0.0222	0.0224	CcSEcCtD
Desoximetasone—Skin striae—Tretinoin—peripheral nervous system neoplasm	0.0217	0.0219	CcSEcCtD
Desoximetasone—Skin striae—Isotretinoin—peripheral nervous system neoplasm	0.0217	0.0219	CcSEcCtD
Desoximetasone—Application site pruritus—Alitretinoin—peripheral nervous system neoplasm	0.0214	0.0216	CcSEcCtD
Desoximetasone—Acneiform eruption—Alitretinoin—peripheral nervous system neoplasm	0.0207	0.0209	CcSEcCtD
Desoximetasone—Dermatitis acneiform—Tretinoin—peripheral nervous system neoplasm	0.0202	0.0204	CcSEcCtD
Desoximetasone—Dermatitis acneiform—Isotretinoin—peripheral nervous system neoplasm	0.0202	0.0204	CcSEcCtD
Desoximetasone—Allergic contact dermatitis—Tretinoin—peripheral nervous system neoplasm	0.0197	0.0199	CcSEcCtD
Desoximetasone—Allergic contact dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.0197	0.0199	CcSEcCtD
Desoximetasone—Secondary infection—Alitretinoin—peripheral nervous system neoplasm	0.0178	0.0179	CcSEcCtD
Desoximetasone—Miliaria—Alitretinoin—peripheral nervous system neoplasm	0.0178	0.0179	CcSEcCtD
Desoximetasone—Skin atrophy—Alitretinoin—peripheral nervous system neoplasm	0.0173	0.0175	CcSEcCtD
Desoximetasone—Skin striae—Alitretinoin—peripheral nervous system neoplasm	0.0164	0.0166	CcSEcCtD
Desoximetasone—Leukoderma—Tretinoin—peripheral nervous system neoplasm	0.0162	0.0164	CcSEcCtD
Desoximetasone—Leukoderma—Isotretinoin—peripheral nervous system neoplasm	0.0162	0.0164	CcSEcCtD
Desoximetasone—Dermatitis acneiform—Alitretinoin—peripheral nervous system neoplasm	0.0153	0.0154	CcSEcCtD
Desoximetasone—Allergic contact dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.015	0.0151	CcSEcCtD
Desoximetasone—Leukoderma—Alitretinoin—peripheral nervous system neoplasm	0.0123	0.0124	CcSEcCtD
Desoximetasone—Pigmentation disorder—Etoposide—peripheral nervous system neoplasm	0.0122	0.0123	CcSEcCtD
Desoximetasone—Folliculitis—Tretinoin—peripheral nervous system neoplasm	0.011	0.0111	CcSEcCtD
Desoximetasone—Folliculitis—Isotretinoin—peripheral nervous system neoplasm	0.011	0.0111	CcSEcCtD
Desoximetasone—Folliculitis—Dactinomycin—peripheral nervous system neoplasm	0.00897	0.00905	CcSEcCtD
Desoximetasone—Stinging—Tretinoin—peripheral nervous system neoplasm	0.00852	0.00859	CcSEcCtD
Desoximetasone—Stinging—Isotretinoin—peripheral nervous system neoplasm	0.00852	0.00859	CcSEcCtD
Desoximetasone—Folliculitis—Alitretinoin—peripheral nervous system neoplasm	0.00832	0.00839	CcSEcCtD
Desoximetasone—Acne—Tretinoin—peripheral nervous system neoplasm	0.0082	0.00827	CcSEcCtD
Desoximetasone—Acne—Isotretinoin—peripheral nervous system neoplasm	0.0082	0.00827	CcSEcCtD
Desoximetasone—Secondary infection—Epirubicin—peripheral nervous system neoplasm	0.00778	0.00785	CcSEcCtD
Desoximetasone—Secondary infection—Doxorubicin—peripheral nervous system neoplasm	0.0072	0.00726	CcSEcCtD
Desoximetasone—Pigmentation disorder—Epirubicin—peripheral nervous system neoplasm	0.00685	0.00691	CcSEcCtD
Desoximetasone—Dermatitis contact—Tretinoin—peripheral nervous system neoplasm	0.00682	0.00688	CcSEcCtD
Desoximetasone—Dermatitis contact—Isotretinoin—peripheral nervous system neoplasm	0.00682	0.00688	CcSEcCtD
Desoximetasone—Stinging—Alitretinoin—peripheral nervous system neoplasm	0.00645	0.00651	CcSEcCtD
Desoximetasone—Pigmentation disorder—Doxorubicin—peripheral nervous system neoplasm	0.00634	0.00639	CcSEcCtD
Desoximetasone—Acne—Alitretinoin—peripheral nervous system neoplasm	0.00621	0.00627	CcSEcCtD
Desoximetasone—Leukoderma—Epirubicin—peripheral nervous system neoplasm	0.00538	0.00543	CcSEcCtD
Desoximetasone—Dermatitis contact—Alitretinoin—peripheral nervous system neoplasm	0.00517	0.00521	CcSEcCtD
Desoximetasone—Leukoderma—Doxorubicin—peripheral nervous system neoplasm	0.00498	0.00502	CcSEcCtD
Desoximetasone—Folliculitis—Epirubicin—peripheral nervous system neoplasm	0.00364	0.00367	CcSEcCtD
Desoximetasone—Psoriasis—Epirubicin—peripheral nervous system neoplasm	0.00364	0.00367	CcSEcCtD
Desoximetasone—Folliculitis—Doxorubicin—peripheral nervous system neoplasm	0.00337	0.0034	CcSEcCtD
Desoximetasone—Psoriasis—Doxorubicin—peripheral nervous system neoplasm	0.00337	0.0034	CcSEcCtD
Desoximetasone—Burning sensation—Epirubicin—peripheral nervous system neoplasm	0.00329	0.00332	CcSEcCtD
Desoximetasone—Burning sensation—Doxorubicin—peripheral nervous system neoplasm	0.00305	0.00307	CcSEcCtD
Desoximetasone—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.00302	0.00304	CcSEcCtD
Desoximetasone—Erythema—Tretinoin—peripheral nervous system neoplasm	0.00302	0.00304	CcSEcCtD
Desoximetasone—Glycosuria—Epirubicin—peripheral nervous system neoplasm	0.00282	0.00285	CcSEcCtD
Desoximetasone—Stinging—Epirubicin—peripheral nervous system neoplasm	0.00282	0.00285	CcSEcCtD
Desoximetasone—Stinging—Doxorubicin—peripheral nervous system neoplasm	0.00261	0.00263	CcSEcCtD
Desoximetasone—Glycosuria—Doxorubicin—peripheral nervous system neoplasm	0.00261	0.00263	CcSEcCtD
Desoximetasone—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.00247	0.00249	CcSEcCtD
Desoximetasone—Infection—Topotecan—peripheral nervous system neoplasm	0.00247	0.00249	CcSEcCtD
Desoximetasone—Infection—Isotretinoin—peripheral nervous system neoplasm	0.00245	0.00247	CcSEcCtD
Desoximetasone—Infection—Tretinoin—peripheral nervous system neoplasm	0.00245	0.00247	CcSEcCtD
Desoximetasone—Infection—Melphalan—peripheral nervous system neoplasm	0.00241	0.00243	CcSEcCtD
Desoximetasone—Triamcinolone—BCHE—peripheral nervous system neoplasm	0.00235	0.287	CrCbGaD
Desoximetasone—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.00229	0.0023	CcSEcCtD
Desoximetasone—Dermatitis contact—Epirubicin—peripheral nervous system neoplasm	0.00226	0.00228	CcSEcCtD
Desoximetasone—Pain—Topotecan—peripheral nervous system neoplasm	0.00212	0.00214	CcSEcCtD
Desoximetasone—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00211	0.00212	CcSEcCtD
Desoximetasone—Pain—Tretinoin—peripheral nervous system neoplasm	0.00211	0.00212	CcSEcCtD
Desoximetasone—Dermatitis contact—Doxorubicin—peripheral nervous system neoplasm	0.00209	0.00211	CcSEcCtD
Desoximetasone—Pain—Melphalan—peripheral nervous system neoplasm	0.00208	0.0021	CcSEcCtD
Desoximetasone—Infection—Dactinomycin—peripheral nervous system neoplasm	0.002	0.00202	CcSEcCtD
Desoximetasone—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00195	0.00196	CcSEcCtD
Desoximetasone—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00185	0.00187	CcSEcCtD
Desoximetasone—Infection—Vincristine—peripheral nervous system neoplasm	0.00179	0.0018	CcSEcCtD
Desoximetasone—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00176	0.00177	CcSEcCtD
Desoximetasone—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00174	0.00176	CcSEcCtD
Desoximetasone—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00174	0.00176	CcSEcCtD
Desoximetasone—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00172	0.00173	CcSEcCtD
Desoximetasone—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00172	0.00173	CcSEcCtD
Desoximetasone—Pain—Alitretinoin—peripheral nervous system neoplasm	0.0016	0.00161	CcSEcCtD
Desoximetasone—Infection—Cisplatin—peripheral nervous system neoplasm	0.00158	0.00159	CcSEcCtD
Desoximetasone—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00156	0.00158	CcSEcCtD
Desoximetasone—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00155	0.00156	CcSEcCtD
Desoximetasone—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00155	0.00156	CcSEcCtD
Desoximetasone—Pain—Vincristine—peripheral nervous system neoplasm	0.00154	0.00155	CcSEcCtD
Desoximetasone—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00153	0.00154	CcSEcCtD
Desoximetasone—Infection—Etoposide—peripheral nervous system neoplasm	0.00145	0.00146	CcSEcCtD
Desoximetasone—Fluticasone furoate—ABCB1—peripheral nervous system neoplasm	0.00137	0.167	CrCbGaD
Desoximetasone—Pain—Cisplatin—peripheral nervous system neoplasm	0.00136	0.00137	CcSEcCtD
Desoximetasone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00132	0.00133	CcSEcCtD
Desoximetasone—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00129	0.00131	CcSEcCtD
Desoximetasone—Pain—Etoposide—peripheral nervous system neoplasm	0.00125	0.00126	CcSEcCtD
Desoximetasone—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.0012	0.00121	CcSEcCtD
Desoximetasone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Desoximetasone—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00113	0.00114	CcSEcCtD
Desoximetasone—Methylprednisolone—ABCB1—peripheral nervous system neoplasm	0.00109	0.133	CrCbGaD
Desoximetasone—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00103	0.00104	CcSEcCtD
Desoximetasone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.001	0.00101	CcSEcCtD
Desoximetasone—Erythema—Epirubicin—peripheral nervous system neoplasm	0.001	0.00101	CcSEcCtD
Desoximetasone—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000925	0.000933	CcSEcCtD
Desoximetasone—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000917	0.000925	CcSEcCtD
Desoximetasone—Prednisone—ABCB1—peripheral nervous system neoplasm	0.000836	0.102	CrCbGaD
Desoximetasone—Infection—Epirubicin—peripheral nervous system neoplasm	0.000811	0.000818	CcSEcCtD
Desoximetasone—Prednisolone—ABCB1—peripheral nervous system neoplasm	0.000771	0.0939	CrCbGaD
Desoximetasone—Betamethasone—ABCB1—peripheral nervous system neoplasm	0.000755	0.092	CrCbGaD
Desoximetasone—Infection—Doxorubicin—peripheral nervous system neoplasm	0.00075	0.000757	CcSEcCtD
Desoximetasone—Pain—Epirubicin—peripheral nervous system neoplasm	0.000698	0.000704	CcSEcCtD
Desoximetasone—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000646	0.000651	CcSEcCtD
Desoximetasone—Hydrocortisone—ABCB1—peripheral nervous system neoplasm	0.000589	0.0718	CrCbGaD
Desoximetasone—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000578	0.000582	CcSEcCtD
Desoximetasone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000534	0.000539	CcSEcCtD
Desoximetasone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000514	0.000518	CcSEcCtD
Desoximetasone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000476	0.00048	CcSEcCtD
Desoximetasone—Dexamethasone—ABCB1—peripheral nervous system neoplasm	0.000439	0.0535	CrCbGaD
